Related Experiment Video

Updated: Feb 26, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.2K

The last frontier: transcatheter devices for percutaneous or minimally invasive treatment of chronic heart failure

V J Nijenhuis1, L Sanchis2, J A S van der Heyden3

  • 1Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands. v.nijenhuis@antoniusziekenhuis.nl.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|July 26, 2017
PubMed

Insights

New transcatheter devices offer novel minimally invasive treatment options for heart failure patients. Early studies show promise for improving outcomes through left ventricular remodelling and pressure reduction, but more clinical evidence is needed.

Area of Science:

  • Cardiology
  • Medical Devices
  • Interventional Cardiology

Background:

  • Heart failure affects a significant portion of the population, with high morbidity and mortality rates.
  • Current treatments, including medications and device therapies, have limitations.
  • Minimally invasive and transcatheter devices are emerging as promising alternatives.

Purpose of the Study:

  • To review novel transcatheter devices for treating chronic heart failure.
  • To focus on interventions targeting left ventricular remodelling, left atrial pressure, tricuspid regurgitation, and neuromodulation.
  • To highlight the early stage of clinical evaluation for these new devices.

Main Methods:

  • Review of current literature on transcatheter devices for heart failure.
  • Focus on devices addressing specific pathophysiological mechanisms.
  • Analysis of early feasibility and safety studies.

Main Results:

  • Rapid development and clinical adoption of transcatheter devices for valvular heart disease.
  • Emerging transcatheter interventions for chronic heart failure are targeting diverse pathophysiological pathways.
  • Early clinical evaluations indicate feasibility and safety for novel devices.

Conclusions:

  • Transcatheter device therapy is rapidly evolving for heart failure management.
  • Further clinical trials are essential to establish the efficacy and long-term benefits of these innovative treatments.
  • These devices represent a significant advancement in the minimally invasive treatment of heart failure.

Keywords:
Heart failureMinimally invasiveNeuromodulationTranscatheterTricuspid regurgitationVentricular aneurysm

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.0K

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
442
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
400
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
520
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
476
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.7K